...
首页> 外文期刊>The Journal of toxicological sciences >Farnesoid X receptor and liver X receptors regulate Oct3/4 expression by multiple feedback regulating system in normal renal-derived cells and renal adenocarcinoma cells
【24h】

Farnesoid X receptor and liver X receptors regulate Oct3/4 expression by multiple feedback regulating system in normal renal-derived cells and renal adenocarcinoma cells

机译:法呢X受体和肝X受体通过在正常肾衍生细胞和肾腺癌细胞中通过多反馈调节系统调节OCT3 / 4表达

获取原文
           

摘要

In this study, we found that nuclear receptors FXR and LXR (originally characterized as regulatory factors involved in cholesterol/bile acid homeostasis) regulate the expression of Oct3/4, a marker for cell differentiation, in both normal renal-derived cell line HK-2 and renal adenocarcinoma cell line ACHN. Down-regulation of Oct3/4 expression by activating FXR and LXR occurs only in normal renal cell-derived HK-2 cells. We also found that the RNA-binding protein, ELAVL2, oppositely regulates Oct3/4 expressions in HK-2 and ACHN cells. Moreover, we revealed that LXR-alpha and LXR-beta regulate each other’s expression. Although an LXR-beta-specific agonist is assumed to be the basis for an anti-arteriosclerotic drug that only stimulates reverse cholesterol transport, our findings show that the development of such an anti-arteriosclerotic drug would require further elucidation of the complex mechanism of LXR-alpha and LXR-beta regulation.
机译:在这项研究中,我们发现核受体FXR和LXR(最初表征为胆固醇/胆汁酸稳态的调节因子)调节OCT3 / 4的表达,在正常肾脏衍生的细胞系HK-中表达细胞分化的标志物。 2和肾腺癌细胞系Achn。通过激活FXR和LXR的OCT3 / 4表达的下调仅在正常的肾细胞衍生的HK-2细胞中发生。我们还发现RNA结合蛋白,ELAVL2,相反地调节HK-2和ACHN细胞中的OCT3 / 4表达。此外,我们透露了LXR-α和LXR-β调节彼此的表达。虽然假设LXR-Beta特异性激动剂是仅刺激逆转胆固醇运输的抗动脉粥样硬化药物的基础,但我们的研究结果表明这种抗动脉粥样硬化药物的发展需要进一步阐明LXR的复杂机制-alpha和lxr-beta规定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号